Physician profile
Sally Pitzer
NPI 1558512699
$937.44
in general payments reported to CMS, 2019-2025
7 companies · $319 in 2025
The $319 reported for 2025 was more than what 90% of Women'S Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2022: $145 · 2023: $142 · 2024: $195 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.91 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $320.38 | 2021-2025 | Uzedy, Austedo Xr, Austedo |
| Janssen Pharmaceuticals, INC | $243.66 | 2021-2024 | Invega Sustenna |
| Alkermes, INC. | $154.44 | 2022-2025 | Aristada, Lybalvi |
| Lundbeck LLC | $125.82 | 2021-2025 | Abilify Asimtufii, Abilify Maintena |
| Otsuka America Pharmaceutical, INC. | $52.08 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $22.56 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Pitzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.